Progressive Care, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 14, 2023 at 06:23 am EDT
Share
Progressive Care, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was USD 11.56 million compared to USD 9.97 million a year ago. Net loss was USD 4.64 million compared to USD 0.880722 million a year ago. Basic loss per share from continuing operations was USD 1.05 compared to USD 0.32 a year ago. Diluted loss per share from continuing operations was USD 1.05 compared to USD 0.32 a year ago.
For the six months, sales was USD 22.95 million compared to USD 20.02 million a year ago. Net loss was USD 4.77 million compared to USD 2.24 million a year ago. Basic loss per share from continuing operations was USD 1.22 compared to USD 0.82 a year ago. Diluted loss per share from continuing operations was USD 1.22 compared to USD 0.82 a year ago.
Progressive Care Inc. is a personalized healthcare services and technology company. It provides prescription pharmaceuticals and risk and data management services to healthcare organizations and providers. It provides prescription pharmaceuticals, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, the supply of prescription medications to long-term care facilities, contracted pharmacy services for 340B covered entities under the 340B Drug Discount Pricing Program, and health practice risk management. It also offers certain disease testing and vaccinations. Its services are designed to provide satisfaction across all medication stakeholders and enhance loyalty and key performance metrics. It offers value-added services at no additional charge, including prior authorization assistance, same-day home-medication delivery, on-site provider consultation services, primary care reporting and analytics, and customized packaging solutions.